15-May-15 10:00 AM  CST

Help For Peanut Allergies May Be on The Horizon

Peanut allergies have gained a lot of attention over the last several years. Some schools are so alarmed by peanut allergies that anything containing peanuts have been banned. There was a time when peanut butter and jelly was synonymous with childhood, but the seriousness of peanut allergies in children has brought this iconic symbolism to a grinding halt.

According to the Centers for Disease Control in 2013 there was a 50% increase in the number of food allergies reported in children between 1997 and 2011. The CDC went on to further state that food allergies in children cost a whooping $25 billion dollars a year. The biggest culprit of childhood related food allergies, peanuts. 0.6% to 1.3% of all children in the U.S. have a severe, life-threatening allergy to peanuts. This may not sound significant, but given that there are nearly 75 million children in the U.S. the numbers add up quite quickly.

The federal Food and Drug Administration announced recently that the ViaSkin Peanut patch would most like receive expedited review. The patch, which is made by the French biologics company, DBV Technologies, uses peanut protein as part of its defense mechanism against the allergic reaction. The ViaSkin patch is the first such patch targeted towards a specific food allergy and is already being tested by Allergist in Seattle, Washington.

Clinical phase III, the last phase prior to final FDA approval, will soon be conducted on hundreds of children in the U.S. Children in the study will be under the age of 12. Many parents look to the patch as an encouraging relief from allergy shots or oral immunotherapy, which is currently the only what to prevent food allergies. If approved by the FDA, DBV expects to ViaSkin Peanut patch to by available by 2018.

 

Resources:

 

Aleccia, J., (2015), “Patch to Treat Peanut Allergies to get Expedited FDA Review” , Seattle Times, http://www.seattletimes.com/seattle-news/health/peanut-patch-to-treat-allergies-to-get-expedited-fda-review/, retrieved 11. April, 2015


For additional information on this article, please contact:
 
Kelley Simmons
 
Source: Sandy Andrews, CPhT, BLS  

Tendenci™ User Home © 2004 Tendenci™ software by Schipul - "The Web Marketing Company" | www.schipul.com